We opted to validate the expression of S1PR2 by immunohistochemistry because this receptor is thought to be more involved in cancer pathogenesis and we confirmed that the S1PR2 was protein was elevated in 39% of tumours. The gene discussed is S1PR2; the disease is cancer.